UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047473
Receipt number R000054139
Scientific Title Team Attitude Rating Scale T-TAQ Validation of Japanese Translation
Date of disclosure of the study information 2022/04/15
Last modified on 2022/10/13 10:36:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Team Attitude Rating Scale T-TAQ Validation of Japanese Translation

Acronym

Verification of validity of T-TAQ Japanese translation

Scientific Title

Team Attitude Rating Scale T-TAQ Validation of Japanese Translation

Scientific Title:Acronym

Verification of validity of T-TAQ Japanese translation

Region

Japan


Condition

Condition

Health care worker

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the reliability and validity of the Japanese translation version of TeamSTEPPS Teamwork Attitudes Questionnaire(T-TAQ)

Basic objectives2

Others

Basic objectives -Others

To translate TeamSTEPPS Teamwork Attitudes Questionnaire(T-TAQ) to Japanese

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

TeamSTEPPS Teamwork Attitudes Questionnaire(T-TAQ)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Health care worker working at Gunma University Hospital

Key exclusion criteria

When there is an offer of refusal

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Kazumi
Middle name
Last name Tanaka

Organization

Gunma University Graduate School of Medicine

Division name

Department of Healthcare Quality and Safety

Zip code

371-8511

Address

3-39-22 Showa machi, Maebashi, Gunma

TEL

027-220-7111

Email

kazumin@gunma-u.ac.jp


Public contact

Name of contact person

1st name Kazumi
Middle name
Last name Tanaka

Organization

Gunma University Graduate School of Medicine

Division name

Department of Healthcare Quality and Safety

Zip code

371-8511

Address

3-39-22 Showa machi, Maebashi, Gunma

TEL

027-220-7111

Homepage URL


Email

kazumin@gunma-u.ac.jp


Sponsor or person

Institute

Gunma University

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gunma University Ethical Review Board for Medical Reserch Involving Human Subjects

Address

3-39-22 Showa machi, Maebashi, Gunma

Tel

027-220-8740

Email

ciru_hitotaisho-irb@ml.gunma-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 09 Month 23 Day

Date of IRB

2021 Year 12 Month 23 Day

Anticipated trial start date

2022 Year 04 Month 18 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We will use opportunities such as the mailing list in Gunma University Hospital andpatient safety training for all staff to explain the purpose of the research and recruit research subjects who will cooperate. After giving detailed explanations to the research subjects who offered to cooperate, we will ask the T-TAQ Japanese translation version (provisional) to respond twice with a three-month period.


Management information

Registered date

2022 Year 04 Month 12 Day

Last modified on

2022 Year 10 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054139


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name